Orange Biomed Shines at Consumer Electronics Show 2025
February 5, 2025
At the Consumer Electronics Show 2025, Orange Biomed showcased the OBM rapid A1c device, advancing healthcare with groundbreaking diabetes care innovation.
At the Consumer Electronics Show 2025, Orange Biomed showcased the OBM rapid A1c device, advancing healthcare with groundbreaking diabetes care innovation.
Discover the key differences, their roles in diabetes care, and how combining CGM and A1C methods can enhance diabetes management and improve health outcomes.
Mayo Clinic Laboratories is a diagnostic lab that conducts in-house tests and studies. Their specialties include cardiology, endocrinology, genetics, gastroenterology, microbiology and infectious diseases, and more.
Healthcare providers–wondering how you can prevent long-term complications by helping your patients catch prediabetes more frequently? Keep reading to find out.
Explore the challenges diabetes management technology poses for older U.S. populations and how tailored solutions can improve care and accessibility.
Diabetes care for patients accounts for 1 in 4 healthcare dollars spent in the U.S. A large part of these costs is spent on diabetes-associated comorbidities.
Can type 2 diabetes be reversed? Learn the facts about lifestyle changes, medical advancements, and key strategies for effective diabetes management.
Stay informed about our launch and get exclusive updates straight to your inbox. Fill out the form below, and we’ll make sure you’re among the first to know when OBM rapid A1c test hits the market.
"*" indicates required fields